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Abstract
Background: The aim of the study was to investigate the effect of aqueous extract of Scoparia
dulcis on the occurrence of oxidative stress in the brain of rats during diabetes by measuring the
extent of oxidative damage as well as the status of the antioxidant defense system.
Methods: Aqueous extract of Scoparia dulcis plant was administered orally (200 mg/kg body
weight) and the effect of extract on blood glucose, plasma insulin and the levels of thiobarbituric
acid reactive substances (TBARS), hydroperoxides, superoxide dismutase (SOD), catalase (CAT),
glutathione peroxidase (GPx), glutathione-S-transferase (GST) and reduced glutathione (GSH)
were estimated in streptozotocin (STZ) induced diabetic rats. Glibenclamide was used as standard
reference drug.
Results: A significant increase in the activities of plasma insulin, superoxide dismutase, catalase,
glutathione peroxidase, glutathione-S-transferase and reduced glutathione was observed in brain
on treatment with 200 mg/kg body weight of Scoparia dulcis plant extract (SPEt) and glibenclamide
for 6 weeks. Both the treated groups showed significant decrease in TBARS and hydroperoxides
formation in brain, suggesting its role in protection against lipidperoxidation induced membrane
damage.
Conclusions: Since the study of induction of the antioxidant enzymes is considered to be a reliable
marker for evaluating the antiperoxidative efficacy of the medicinal plant, these findings suggest a
possible antiperoxidative role for Scoparia dulcis plant extract. Hence, in addition to antidiabetic
effect, Scoparia dulcis possess antioxidant potential that may be used for therapeutic purposes.
Background
The neurological consequences of diabetes mellitus in the
Central Nervous System (CNS) are now receiving greater
attention. Cognitive deficits, along with morphological
and neurochemical alterations illustrate that the neuro-
logical complications of diabetes are not limited to
peripheral neuropathies [1]. The central complications of
hyperglycemia also include the potentiation of neuronal
damage observed following hypoxic/ischemic events, as
well as stroke [2]. Glucose utilization is decreased in the
brain during diabetes [2], providing a potential mecha-
nism for increased vulnerability to acute pathological
events.
Oxidative stress, leading to an increased production of
reactive oxygen species (ROS), as well as
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lipidperoxidation, is increased in diabetes [3] and also by
stress in euglycemic animals [4]. Similarly, oxidative dam-
age in rat brain is increased by experimentally induced
hyperglycemia [5]. Under experimental conditions,
hyperglycemia dramatically increases neuronal altera-
tions and glial cell damage caused by temporary ischae-
mia [6]. Several lines of evidence indicate that the
modified oxidative state induced by chronic hyperglyc-
emia [7] may contribute to nervous tissue damage: free
radical species impair the central nervous system, attack-
ing neurons and schwann cells [8] and the peripheral
nerves [9]. Due to their high polyunsaturated lipid con-
tent, schwann cells and axons are particularly sensitive to
oxygen free radical damage: lipidperoxidation may
increase cell membrane rigidity and impair cell function.
Increases in superoxide production are observed in the
serum of Type 1 diabetic patients and was reduced with
improved glycemic control [10]. Lipidperoxidation prod-
ucts are also increased in the brains of Type 1 diabetic rats
[11] and Type 2 diabetic mice [8]. Diabetes and stress
mediated increases in oxidative stress, as well as decreases
in antioxidant activity, may make the brain more vulner-
able to subsequent pathological events.
Nowadays, the use of complementary/alternative medi-
cine and especially the consumption of botanicals have
been increasing rapidly worldwide, mostly because of the
supposedly less frequent side effects when compared to
modern western medicine [12]. Scoparia dulcis L (Scrophu-
lariacae), a folk-medicinal plant known as sweet
broomweed, has been used as a remedy for diabetes mel-
litus in India [13] and for hypertension in Taiwan [14,15].
A number of active principles from Scoparia dulcis include
scoparic acid A, scoparic acid B and scoparic acid D [16],
scopadulcic acid A and B, scopadulciol [17] and Scopadu-
lin [18] that have been identified as contributor to the
observed medicinal effect of the plant. Among them, sco-
padulcic acid B (SDB) and scopadulciol (SDC) were
found to be unique biomolecules with inhibitory effects
on replication of herpes simplex virus type 1 (HSV-1)
[16], gastric proton pump and bone resorption stimulated
by parathyroid hormone (PTH) [18]. In addition, SDB
showed antitumour promoting activities [17]. Because of
their unique carbon skeleton and many sided biological
activities, they were paid much attention as chemical syn-
thetic targets by organic synthetic chemists. In a previous
study, Nath (1943) studied the antidiabetic effect of Sco-
paria dulcis and obtained a glycoside, amellin from fresh
plant and reported that it brought relief in other compli-
cations accompanied with diabetes (ie., pyorrhoea, retin-
opathy, joint pain, susceptibility to cold etc.) within a very
short period [19].
Administration of Scoparia dulcis to STZ diabetic rats led to
reduction in blood glucose [20]. In Recent studies on this
plant, we have demonstrated a defective metabolism of
lipid peroxides in tissues (liver, kidney and brain) of STZ
diabetic rats [21] for 3 weeks treatment. Since increases in
oxidative stress are associated with both long standing
diabetes and stress, the present investigation was to assess
the antioxidant efficacy of Scoparia dulcis in STZ diabetic
rats after 6 weeks treatment and the effect produced by
Scoparia dulcis was compared with Glibenclamide.
Methods
Animals
Adult male albino Wistar rats (8 weeks), weighing 180–
200 g bred in the Central Animal House, Rajah Muthiah
Medical College, Annamalai University, were used. All
animal experiments were approved by the ethical commit-
tee (Vide. No: 73, 2002), Annamalai University and were
in accordance with the guidelines of the National Institute
of Nutrition, Indian Council of Medical Research, Hydera-
bad, India. The animals were fed ad libitum with normal
laboratory pellet diet (Hindustan Lever Ltd., India) and
water. Animals were maintained under a constant 12 h
light and dark cycle and at an environmental temperature
of 21–23°C.
Drugs and chemicals
All the drugs and biochemicals used in this experiment
were purchased from Sigma Chemical Company Inc., St
Louis, Mo, USA. The chemicals were of analytical grade.
Plant material
Whole plants of Scoparia dulcis L. (40 – 60 cm in height)
were collected from Neyveli, Cuddalore District, Tamil
Nadu, India in September 2001. The plant was identified
and authenticated at the Herbarium of Botany Directorate
in Annamalai University. A voucher specimen (No.3412)
was deposited in the Botany Department of Annamalai
University.
Preparation of Scoparia dulcis plant extract (SPEt)
Five-hundred grams of fresh whole Scoparia dulcis plants
were extracted with 1.5 l of water by the method of con-
tinuous hot extraction at 60°C for 6 h according to Jain
(1968) and the filtrate was concentrated at 40°C to con-
stant weight in a rotavapor apparatus (Buchi Labortechnik
AG, Switzerland). The residue collected (yield 31 g) were
thick paste, green in color and gumaceaous in nature and
stored at -20°C, when needed the extract was dissolved in
sterile water and used in the investigation [22].
Induction of experimental diabetes
STZ, freshly prepared in 10 mmol/l citrate buffer, pH 4.5,
was injected to experimental animals (30 rats) intraperito-
neally at a dose of 45 mg/kg body weight [23]. 48 h afterBMC Complementary and Alternative Medicine 2004, 4:16 http://www.biomedcentral.com/1472-6882/4/16
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STZ administration, rats with moderate diabetes having
glycosuria and hyperglycemia (i.e with blood glucose of
200 – 300 mg/dl) were taken for the experiment.
Experimental design
In the experiment, a total of 30 rats (18 diabetic surviving
rats, 12 normal rats) were used. The rats were divided into
5 groups of 6 rats each. Group 1: Normal rats. Group 2:
Normal rats given Scoparia dulcis plant extract (SPEt) (200
mg/kg body weight) in aqueous solution daily using an
intragastric tube for 6 weeks. Group 3: Diabetic control
rats. Group 4: Diabetic rats given SPEt (200 mg/kg body
weight) [21] in aqueous solution daily using an intragas-
tric tube for 6 weeks. Group 5: Diabetic rats given Gliben-
clamide (600 µg/kg body weight) in aqueous solution
daily using an intragastric tube for 6 weeks [24].
All doses were started after 48 h STZ injection. No detect-
able irritation or restlessness was observed after each drug
or vehicle administration. No noticeable adverse effect
(i.e., respiratory distress, abnormal locomotion and cata-
lepsy) was observed in any animals after the drug admin-
istration. Blood samples were drawn at weekly intervals
till the end of study (ie. 6 weeks). At the end of 6th week,
all the rats were killed by decapitation (Pentobarbitone
sodium) anaesthesia (60 mg/kg). Blood was collected in
two different tubes (i.e.,) one with anticoagulant – potas-
sium oxalate and sodium fluoride for plasma and another
without anticoagulant for serum separation. Plasma and
serum were separated by centrifugation. Whole Brain was
immediately dissected out, washed in ice cold saline to
remove the blood. The brains were weighed and 10% tis-
sue homogenate was prepared with 0.025 M Tris – HCl
buffer, pH 7.5. After centrifugation at 200 rpm for 10 min,
the clear supernatant was used to measure thiobarbituric
acid reactive substances (TBARS), hydroperoxides and
GPx activity. For the assay of SOD, CAT, GST and GSH, the
brains were weighed and 10% homogenate was prepared
with 0.2 M, phosphate buffer pH 8.0. After centrifugation,
the clear supernatant was used for the assay of enzyme
activities.
Biochemical analysis
Estimation of blood glucose and plasma insulin
Blood glucose was determined by the O-toluidine method
[25]. Plasma insulin was assayed by ELISA, using Boe-
heringer-Mannheim Kit with a Boeheringer analyser
ES300.
Estimation of lipid peroxidation
Lipid peroxidation in brain was estimated colorimetri-
cally by thiobarbituric acid reactive substances TBARS and
hydroperoxides by the method of Niehius and Samuels-
son [26] and Jiang et al. [27], respectively. In brief, 0.1 ml
of tissue homogenate (Tris-Hcl buffer, pH 7.5) was treated
with 2 ml of (1:1:1 ratio) TBA-TCA-HCl reagent (thiobar-
bituric acid 0.37%, 0.25 N HCl and 15% TCA) and placed
in water bath for 15 min, cooled. The absorbance of clear
supernatant was measured against reference blank at 535
nm.
0.1 ml of tissue homogenate was treated with 0.9 ml of
Fox reagent (88 mg butylated hydroxytoluene (BHT), 7.6
mg xylenol orange and 9.8 mg ammonium ion sulphate
were added to 90 ml of methanol and 10 ml 250 mM sul-
phuric acid) and incubated at 37°C for 30 min. The color
developed was read at 560 nm colorimetrically.
Hydroperoxides was expressed as mM/100g tissue.
Assay of catalase (CAT) and superoxide dismutase (SOD)
CAT was assayed colorimetrically at 620 nm and
expressed as µmoles of H2O2 consumed/min/mg protein
as described by Sinha [28]. The reaction mixture (1.5 ml,
vol) contained 1.0 ml of 0.01 M pH 7.0 phosphate buffer,
0.1 ml of tissue homogenate (supernatant) and 0.4 ml of
2 M H2O2. The reaction was stopped by the addition of
2.0 ml of dichromate-acetic acid reagent (5% potassium
dichromate and glacial acetic acid were mixed in 1:3
ratio).
SOD was assayed utilizing the technique of Kakkar et al.
[29] based on inhibition of the formation of nicotina-
mide adenine dinucleotide, phenazine methosulfate and
amino blue tetrazolium formazan. A single unit of
enzyme was expressed as 50% inhibition of NBT (Nitrob-
lue tetrazolium) reduction/min/mg protein.
Determination of glutathione peroxidase (GPx) and reduced 
glutathione (GSH)
GPx activity was measured by the method described by
Rotruck et al. [30]. Briefly, reaction mixture contained 0.2
ml of 0.4 M Tris-HCl buffer pH 7.0, 0.1 ml of 10 mM
sodium azide, 0.2 ml of tissue homogenate (homoge-
nised in 0.4 M, Tris-HCl buffer, pH 7.0), 0.2 ml glutath-
ione, 0.1 ml of 0.2 mM hydrogen peroxide. The contents
were incubated at 37°C for 10 min. The reaction was
arrested by 0.4 ml of 10% TCA, and centrifuged. Superna-
tant was assayed for glutathione content by using Ellmans
reagent (19.8 mg of 5,5'-dithiobisnitro benzoic acid
(DTNB) in 100 ml of 0.1% sodium nitrate).
GSH was determined by the method of Ellman [31]. 1.0
ml of supernatant was treated with 0.5 ml of Ellmans rea-
gent and 3.0 ml of phosphate buffer (0.2 M, pH 8.0). The
absorbance was read at 412 nm. Glutathione peroxidase
activity was expressed as µg of GSH consumed/min/mg
protein and reduced glutathione as mg/100g of tissue.BMC Complementary and Alternative Medicine 2004, 4:16 http://www.biomedcentral.com/1472-6882/4/16
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Determination of glutathione-S-transferase (GST)
The GST activity was determined spectrophotometrically
by the method of Habig et al. [32]. The reaction mixture
(3 ml) contained 1.0 ml of 0.3 mM phosphate buffer (pH
6.5), 0.1 ml of 30 mM 1-chloro-2, 4-dinitrobenzene
(CDNB) and 1.7 ml of double distilled water. After pre-
incubating the reaction mixture at 37°C for 5 min, the
reaction was started by the addition of 0.1 ml of tissue
homogenate and 0.1 ml of glutathione as substrate. The
absorbance was followed for 5 min at 340 nm. Reaction
mixture without the enzyme was used as blank. The activ-
ity of GST is expressed as µmoles of GSH-CDNB conjugate
formed/min/mg protein using an extinction coefficient of
9.6 mM-1 cm-1.
Estimation of protein
Protein was determined by the method of Lowry et al. [33]
using Bovine Serum Albumin (BSA) as standard, at 660
nm.
Statistical analysis
All data were expressed as mean ± SD of number of exper-
iments (n = 6). The statistical significance was evaluated
by one-way analysis of variance (ANOVA) using SPSS ver-
sion 7.5 (SPSS, Cary, NC, USA) and the individual com-
parison were obtained by Duncan's Multiple Range Test
(DMRT). A value of p < 0.05 was considered to indicate a
significant difference between groups [34].
Results
Table 1 shows the level of blood glucose and plasma insu-
lin in normal and experimental groups. The level of blood
glucose was significantly increased whereas the level of
plasma insulin was significantly decreased in diabetic
control rats. Oral administration of SPEt and glibencla-
mide to diabetic rats significantly reversed all these
changes to near normal levels.
Table 2 illustrates markers of lipidperoxidatioon namely,
TBARS and hydroperoxides from brain of normal and
experimental rats. The levels of TBARS and hydroperox-
ides were significantly increased in diabetic control rats.
Administration of SPEt to diabetic rats significantly
decreased the levels of lipidperoxidative markers. Treat-
ment of normal rats with SPEt did not show significant
changes in lipidperoxidation. The effect produced by SPEt
was significant than glibenclamide.
Table 1: Effect of Scoparia dulcis on blood glucose and plasma insulin in normal and experimental rats
Groups Fasting blood glucose (mg/dl) Plasma insulin (µu/ml)
Normal 84 ± 4a 12 ± 1a
Normal + SPEt (200 mg/kg) 77 ± 3a 15 ± 1b
Diabetic control 270 ± 15b 4 ± 0.3c
Diabetic + SPEt (200 mg/kg) 98 ± 3c 11 ± 4d
Diabetic + Glibenclamide (600 µg/kg) 114 ± 9d 9 ± 0.5e
Values are given as mean ± SD from 6 rats in each group.
Values not sharing a common superscript letter differ significantly at p < 0.05 (DMRT); Duncan Procedure; Ranges for the level: 2.95, 3.09, 3.20, 
3.22.
Table 2: Change in the levels of brain TBARS and hydroperoxides in normal and experimental rats
Groups TBARS (mM/100g tissue) Hydroperoxides (mM/100g tissue)
Normal 1.10 ± 0.08a 113.20 ± 4.10a
Normal + SPEt (200 mg/kg) 0.90 ± 0.05a 108.70 ± 2.20b
Diabetic control 1.85 ± 0.07b 130.90 ± 1.50c
Diabetic + SPEt (200 mg/kg) 1.18 ± 0.06c 117.22 ± 3.26d
Diabetic + Glibenclamide (600 µg/kg) 1.32 ± 0.06d 120.40 ± 4.05e
Values are given as mean ± SD for 6 rats in each group.
Values not sharing a common superscript letter differ significantly at p < 0.05 (DMRT).
Duncan procedure, Range for the level 2.95, 3.09, 3.20, 3.22.BMC Complementary and Alternative Medicine 2004, 4:16 http://www.biomedcentral.com/1472-6882/4/16
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For studying the effect of SPEt on antioxidant status, the
activities of enzymic antioxidants SOD, CAT, GPx, GST
and non-enzymic antioxidant GSH were measured (Table
3 and 4). The activities of enzymic and the levels of non-
enzymic antioxidant were significantly decreased in dia-
betic control rats. They presented significant increases in
diabetic rats treated SPEt. Administration of SPEt to nor-
mal rats increased the antioxidants levels with no signifi-
cant differences. The effect produced by SPEt was
comparable with that of glibenclamide.
Discussion
This work is one of a series of studies showing that chronic
hyperglycemia causes an imbalance in the oxidative status
of the nervous tissue and that the resulting free radicals
damage the brain through a peroxidative mechanism. The
STZ diabetic rat serves as an excellent model to study the
molecular, cellular and morphological changes in brain
induced by stress during diabetes [7]. Under normal con-
ditions, the generation of free radicals or of active species
in the brain, as in other tissues, is maintained at extremely
low levels [4]. Diabetes also contributes to cerebrovascu-
lar complications, reductions in cerebral blood flow, dis-
ruption of the blood brain barrier and cerebral edema [5].
All of these neurochemical and neurophysiological
changes ultimately contribute to the long-term complica-
tions associated with diabetes, including morphological
abnormalities, cognitive impairments and increased vul-
nerability to pathophysiological event [6].
In the present study, treatment with aqueous extract of
Scoparia dulcis showed significant antihyperglycemic
activity. The antihyperglycemic activity of this plant may
be, at least in part, through release of insulin from the
pancreas in view of the measured increase in the plasma
insulin concentrations.
Earlier studies in this lab have demonstrated a defective
metabolism of lipid peroxides in other tissues of diabetic
animal [35,36]. TBARS and hydroperoxides (lipid peroxi-
dative markers) showed high lipidperoxidation. This may
be because; the brain contains relatively high concentra-
tion of easily peroxidizable fatty acids [37]. In addition, it
is known that certain regions of the brain are highly
Table 3: Changes in activities of catalase and superoxide dismutase in brain of normal and experimental rats
Groups Catalase (UnitsA/mg protein) Superoxide dismutase (UnitsB/mg 
protein)
Normal 3.12 ± 0.29a 7.75 ± 0.38a
Normal + SPEt (200 mg/kg) 4.00 ± 0.20b 7.05 ± 0.28a
Diabetic control 0.86 ± 0.05c 5.17 ± 0.30b
Diabetic + SPEt (200 mg/kg) 2.75 ± 0.20d 7.32 ± 0.46c
Diabetic + Glibenclamide (600 µg/kg) 1.98 ± 0.11e 6.32 ± 0.30d
Values are given as mean ± SD for 6 rats in each group.
Values not sharing a common superscript letter differ significantly at p < 0.05 (DMRT).
Duncan procedure, Range for the level 2.95, 3.09, 3.20, 3.22.
A – µmole of H2O2 consumed/minute.
B – One unit of activity was taken as the enzyme reaction, which gave 50% inhibition of NBT reduction in one minute.
Table 4: Changes in activities of glutathione peroxidase, glutathione-S-transferase and the levels of reduced glutathione in brain of 
normal and experimental rats
Groups Glutathione peroxidase 
(UnitsA/mg protein)
Glutathione-S-transferase 
(UnitsB/mg protein)
Reduced glutathione (mg/
100g tissue)
Normal 3.4 1± 0.20a 5.62 ± 0.28a 35.19 ± 2.21a
Normal + SPEt (200 mg/kg) 3.80 ± 0.18a 5.90 ± 0.28a 37.12 ± 2.14a
Diabetic control 1.01 ± 0.05b 0.81 ± 0.02b 15.20 ± 1.44b
Diabetic + SPEt (200 mg/kg) 2.62 ± 0.15c 2.10 ± 0.13c 26.02 ± 2.01c
Diabetic + Glibenclamide (600 µg/kg) 1.97 ± 0.12d 2.04 ± 0.13c 25.50 ± 2.10c
Values are given as mean ± SD for 6 rats in each group.
Values not sharing a common superscript letter differ significantly at p < 0.05 (DMRT).
Duncan procedure, Range for the level 2.95, 3.09, 3.20, 3.22.
A – µg of GSH consumed/min.
B – µmoles of CDNB – GSH conjugate formed/min.BMC Complementary and Alternative Medicine 2004, 4:16 http://www.biomedcentral.com/1472-6882/4/16
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enriched in iron, a metal that, in its free form, is catalyti-
cally involved in production of damaging oxygen free rad-
ical species [38]. It has been suggested that free radical
species responsible for STZ toxicity is the hydroxyl radical,
formed via the metal catalyzed Haber-weiss reaction or
Fenton reaction. In this process, the ferric iron is reduced
by superoxide, with subsequent oxidation of ferrous iron
by H2O2 forming hydroxyl radical:
Fe3+ + O2
•- → Fe2+ + O2
Fe2+ + H2O2 → Fe3+ + OH* + OH-
The destruction of superoxide radical or H2O2 by SOD or
CAT would ameliorate STZ toxicity, as would substances
able to scavenge the hydroxyl radical [39,40]. Vulnerabil-
ity of brain to oxidative stress induced by oxygen free rad-
icals seems to be due to the fact that, on one hand, the
brain utilizes about one fifth of the total oxygen demand
of the body and on the other, that it is not particularly
enriched, when compared with other organs, in any of the
antioxidant enzymes. Relatively low levels of these
enzymes may be responsible in part for the vulnerability
of this tissue [41].
The altered balance of the antioxidant enzymes caused by
decrease in CAT, SOD, GPx, GST and GSH activities may
be responsible for the inadequacy of the antioxidant
defenses in combating ROS mediated damage. The
decreased activities of CAT and SOD may be a response to
increased production of H2O2 and O2 by the autoxidation
of glucose and non-enzymatic glycation [5]. These
enzymes have been suggested as playing an important
role in maintaining physiological levels of oxygen and
hydrogen peroxide by hastening the dismutation of oxy-
gen radicals and eliminating organic peroxides and
hydroperoxides generated from inadvertent exposure to
STZ [42]. Treatment with SPEt increased the activity of
enzymes and may help to control free radicals, as Scoparia
dulcis has been reported to be rich in alkaloids and terpe-
noids [16-18,43,44], well-known antioxidants, which
scavenge the free radicals generated during diabetes. The
increase in SOD activity may protect CAT and GPx against
inactivation by O2
•- anions as these anions have been
shown to inactivate CAT and GPx [45].
Under in vivo conditions, GSH acts as an antioxidant and
its decrease was reported in diabetes mellitus [46]. We
have observed significant decrease in GSH levels in brain
during diabetes. The decrease in GSH levels represents
increased utilization due to oxidative stress [47]. The
depletion of GSH content may also lower the GST activity
[48]. Depression in GPx activity was also observed brain
of diabetic rats. GPx has been shown to be an important
adaptive response to condition of increased peroxidative
stress [46]. The increased GSH content in the brain of the
rats treated with SPEt and glibenclamide may be a factor
responsible for inhibition of lipidperoxidation. The ele-
vated level of GSH protects cellular proteins against oxida-
tion through glutathione redox cycle and also directly
detoxifies reactive oxygen species generated from expo-
sure to STZ [48]. The significant increase in GSH content
and GSH dependent enzymes GPx and GST in diabetic
rats treated with SPEt indicates an adaptive mechanism in
response to oxidative stress.
Significantly lower levels of lipid peroxides in brain of
SPEt treated diabetic rats and increased activities of
enzymic and non-enzymic antioxidants in brain suggest
that the extract reduce oxidative stress by quenching free
radicals. Terpenoids and alkaloids were reported to have
free radical scavenging activity and antioxidant capacity in
diabetes [49,50]. SPEt was reported to be rich in an alka-
loid-6-methoxybenzoxazolinone [51] and terpenoids
such as scoparic acids A, B, C and scopadulcic acids A and
B [16-18], which may be responsible for scavenging free
radicals liberated by STZ and thus enhance both enzymic
and non-enzymic antioxidants in diabetic rats treated
with SPEt. Any compound, natural or synthetic with anti-
oxidant properties that might contribute towards the
partial or total alleviation of this damage may have a sig-
nificant role in the treatment of diabetes mellitus. The
antioxidant responsiveness mediated by Scoparia dulcis
may be anticipated to have biological significance in elim-
inating reactive free radicals that may otherwise affect the
normal cell functioning. The disfunctioning of these anti-
oxidant enzymes has been implicated in several disorders
including rheumatoid arthritis, reperfusion injury, cardio-
vascular diseases, immune injury as well as diabetes mel-
litus [52].
It may be concluded that in diabetes, brain tissue was
more vulnerable to oxidative stress and showed increased
lipidperoxidation. The above observation shows that the
aqueous extract of Scoparia dulcis plant possesses antioxi-
dant activity, which could exert a beneficial action against
pathological alterations caused by the presence of free
radicals in STZ diabetes.
Conclusions
The brain exhibits numerous morphological and func-
tional alterations during diabetes. Oxidative stress, a fac-
tor implicated in the pathogenesis of diabetic
complications may contribute towards some of these
alterations. Treatment of diabetic rats with Scoparia dulcis
plant extract significantly decreased the lipidperoxidation
and significantly increased the antioxidant status. Since
the study of induction of the antioxidant enzymes is con-
sidered to be a reliable marker for evaluating the antioxi-
dant efficacy of the medicinal plant, these findings areBMC Complementary and Alternative Medicine 2004, 4:16 http://www.biomedcentral.com/1472-6882/4/16
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suggestions of possible antioxidant role played by Scoparia
dulcis plant extract in addition to its antidiabetic effect.
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